Le Lézard
Classified in: Health, Business
Subjects: NPT, LEG, FOR, POL, AVO

Judge Blocks Trump Effort to Curtail Immigrant Costs to Taxpayers: FAIR Statement and Analysis


WASHINGTON, Nov. 27, 2019 /PRNewswire/ -- U.S. District Court Judge Michael Simon, sitting in Portland, Oregon, has issued a preliminary injunction blocking the Trump administration's requirement that immigrants either obtain health insurance, or demonstrate they can pay for medical care, before the Department of State (DOS) may grant them visas. This preliminary injunction is effective nationwide.

The Federation for American Immigration Reform (FAIR) is a national, nonprofit, public-interest, membership organization of concerned citizens who share a common belief that our nation's immigration policies must be reformed to serve the national interest. Visit FAIR's website at  www.fairus.org . (PRNewsFoto/FAIR)

Judge Simon's action was allegedly motivated by apprehension that the new policy would separate individuals who plan to migrate to the United States from family members who already reside here. But while the judge expressed baseless concern that the Trump administration was "re-writing" the Immigration and Nationality Act, he appears to have unilaterally redefined immigrant visas as a statutory entitlement, guaranteed to any foreign national who demands one. However, by that logic, virtually all inadmissibility criteria are impermissible and the U.S. would be obligated to admit even violent criminals and terrorists who have applied for a family-based visa.

In addition, Judge Simon appears to have completely ignored the line of Supreme Court cases on this issue, beginning with Phelps v. London (1929) culminating with Kerry v. Din (2015), which clearly hold that there is no constitutionally protected right entitling foreign nationals to join their relatives in the United States. As such, there is a serious question as to whether the court was even entitled to review this matter or whether it should have summarily dismissed it for failure to state a valid cause of action.

Moreover, it is a settled matter that visa decisions made by consular officers are not subject to review by the courts of the United States. Similarly, Executive Branch guidelines dictating how DOS personnel should adjudicate visa applications have repeatedly been held to fall within the "plenary power doctrine" ? the legal rule holding that the President possesses an unreviewable power to take action on matters that affect U.S. sovereignty.

This ruling is only the latest from within the notoriously anti-Trump Ninth Federal Judicial Circuit, which has repeatedly engaged in torturous interpretations of immigration law in order to elevate the interests of foreign nationals over the public safety and economic security concerns of U.S. citizens. It remains to be seen whether this misguided decision will be overruled by the Supreme Court. Meanwhile, Americans remain responsible for shouldering the massive healthcare bill for recently arrived immigrants who can't afford insurance.

Contact: Matthew Tragesser, 202-328-7004

ABOUT FAIR        

Founded in 1979, FAIR is the country's largest immigration reform group. With over 2 million members and supporters nationwide, FAIR fights for immigration policies that serve national interests, not special interests. FAIR believes that immigration reform must enhance national security, improve the economy, protect jobs, preserve our environment, and establish a rule of law that is recognized and enforced.

SOURCE Federation for American Immigration Reform (FAIR)


These press releases may also interest you

at 08:22
The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit...

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...



News published on and distributed by: